Farallon Capital Management LLC Cara Therapeutics, Inc. Call Options Transaction History
Farallon Capital Management LLC
- $19.9 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CARA
# of Institutions
74Shares Held
12.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$944,5420.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$714,8860.06% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.11MShares$467,4780.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$465,7510.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny866KShares$363,8460.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $22.6M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...